# Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome

> **NCT02180516** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 9984 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Meloxicam
- **DRUG:** Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac

## Key facts

- **NCT ID:** NCT02180516
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2004-09
- **Final completion:** —
- **Target enrollment:** 9984 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02180516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02180516, "Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02180516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*